Updated Jul 16, 2026 · Last SEC filing 2026-06-17
HERON THERAPEUTICS, INC. /DE/ (HRTX) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-17. 4 Form 8-K material event filings were reported by HRTX in the last 90 days. InsiderAlpha tracks every HRTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0000818033 |
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Latest Form 4 filing | 2026-06-17 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Duarte Ira | EVP, Chief Financial Officer | M — Option exercise | 12.5K | — | — | SEC | |
| Duarte Ira | EVP, Chief Financial Officer | F — Tax withholding / forfeiture | 3.6K | $0.38 | $1K | SEC | |
| Forbes William P | EVP, Chief Development Officer | M — Option exercise | 12.5K | — | — | SEC | |
| Hensley Mark Earl | Chief Operating Officer | M — Option exercise | 125.0K | — | — | SEC | |
| Collard Craig A | Chief Executive Officer | M — Option exercise | 34.8K | — | — | SEC | |
| Hensley Mark Earl | Chief Operating Officer | M — Option exercise | 11.8K | — | — | SEC | |
| Forbes William P | EVP, Chief Development Officer | M — Option exercise | 11.7K | — | — | SEC | |
| Collard Craig A | Chief Executive Officer | M — Option exercise | 50.0K | — | — | SEC | |
| Duarte Ira | EVP, Chief Financial Officer | M — Option exercise | 11.7K | — | — | SEC | |
| Duarte Ira | EVP, Chief Financial Officer | M — Option exercise | 13.5K | — | — | SEC | |
| Forbes William P | EVP, Chief Development Officer | M — Option exercise | 11.8K | — | — | SEC | |
| Duarte Ira | EVP, Chief Financial Officer | M — Option exercise | 3.9K | — | — | SEC | |
| Forbes William P | EVP, Chief Development Officer | M — Option exercise | 3.9K | — | — | SEC | |
| Collard Craig A | Chief Executive Officer | M — Option exercise | 13.8K | — | — | SEC | |
| Collard Craig A | Chief Executive Officer | M — Option exercise | 62.5K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for HERON THERAPEUTICS, INC. /DE/ (HRTX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Duarte Ira | 9 | $1K |
| Forbes William P | 8 | — |
| Collard Craig A | 6 | — |
| Hensley Mark Earl | 4 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in HRTX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live HRTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.